A Nevada jury is ordering pharmaceutical companies to pay $162.5 million in punitive damages in a lawsuit stemming from a Las Vegas hepatitis C outbreak in 2008.
The damages awarded Monday in Clark County District Court are on top of the $20.1 million in compensatory damages awarded to five plaintiffs Thursday after a jury found Teva Parenteral Medicines Inc., Baxter Healthcare Corp. and McKesson Corp. liable after a seven-week trial.
Plaintiffs’ lawyers had been seeking $600 million in punitive damages.
At least one of the drug companies is planning an immediate appeal.
Plaintiffs accused the drug companies of distributing dangerously large vials of the powerful anesthetic propofol to clinics where doctors and anesthesiologists are suspected of reusing vials – despite warnings that the practice could spread blood-borne diseases.
Was this article valuable?
Here are more articles you may enjoy.
Even Low-Risk Homes Are Caught Up in California’s Climate Insurance Crisis
BofA Agrees to Settle Claims It Aided Epstein Sex Crimes
Meta, Google Pivot in Addiction Trial to Accuser’s Home Life
AI May Be Tempering Insurer Hiring, New Analysis Shows